Skip to main content

Table 1 Demographic characteristics and clinical manifestations of the patient population (n = 210)

From: Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China

Sociodemographic characteristics Descriptive
 Age (years), mean (SD) 36.44 (12.83)
 Sex, female, n (%) 191 (90.95)
 Marital status, n (%)
  Married 148 (70.48)
  Other marital status 62 (29.52)
 Education level, n (%)
  Primary (0–6 years) 27 (12.86)
  Secondary (7–12 years) 78 (37.14)
  Higher (>12 years) 105 (50.00)
 Employment, n (%)
  Employed 105 (50.00)
  Unemployed 105 (50.00)
Disease characteristic Descriptive
 Disease duration, n (%)
  <1 year 12 (5.71)
  1–5 year 98 (46.67)
   ≥ 5 year 100 (47.62)
 Comorbidities, n (%)
  0 75 (35.71)
  1 75 (35.71)
  2 33 (15.71)
   ≥ 3 27 (12.86)
 EQ-5D Index, mean (SD) 0.72 (0.26)
  SLEDAI-2 K
  0–4 98 (46.67)
  5–9 50 (23.81)
  10–14 41 (19.52)
   ≥ 15 21 (10.00)
 SLICC Index, mean (SD) 0.87(1.26)
Treatment characteristic Descriptive
 Types of pills prescribed daily, mean (SD) 4.86 (2.20)
 Use of GC, n (%) 198 (94.29)
 Number of immunomodulators&immunosuppressants, mean (SD) 0.89 (0.70)
 Use of NSAID, n (%) 18 (8.57)
 Use of biologic drugs, n (%) 22 (10.47)
 Daily dosing frequency, n (%)
  < once daily 27 (12.86)
  once daily 46 (21.90)
  Twice daily 87 (41.43)
  Thrice daily 47 (22.38)
  > Thrice daily 3 (1.43)
 Side effects, n (%)
  0 175(83.33)
  1–2 28(13.33)
   ≥ 3 7 (3.33)
 CQR19, mean (SD) 74.06 (8.93)
  1. Abbreviations: CQR compliance questionnaire rheumatology, EQ-5D EuroQol five-dimensions, GC glucocorticoid, NSAID non-steroidal anti-inflammatory drug, SD standard deviation, SLEDAI systemic lupus erythematosus disease activity index, SLICC the Systemic Lupus International Collaborating Clinics